IL-6 plays an important role in the tumor-related systemic inflammatory response, not only as a major inducer of CRP [47] but also as a direct inducer of anti-inflammatory molecules [48], which are also considered potential mechanisms by which IL-6 participates in the occurrence of irAEs. The gene discussed is IL6; the disease is neoplasm.